BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27617314)

  • 21. Are bladder neoplasms more aggresive in patients with a smoking-related second malignancy?
    Otunctemur A; Koklu I; Ozbek E; Dursun M; Sahin S; Besiroglu H; Erkoc M; Danis E; Bozkurt M; Gurbuz A
    Asian Pac J Cancer Prev; 2014; 15(9):4025-8. PubMed ID: 24935590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer.
    Kagei K; Hosokawa M; Shirato H; Kusumi T; Shimizu Y; Watanabe A; Ueda M
    Jpn J Clin Oncol; 2002 Apr; 32(4):120-7. PubMed ID: 12072421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal trends in competing mortality from second and subsequent primary cancers, 1980-2014: An Australian population-based study.
    Ye Y; Otahal P; Wills KE; Neil AL; Venn AJ
    Cancer Epidemiol; 2018 Aug; 55():61-67. PubMed ID: 29803142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contribution of second primary cancers to the mortality of patients with a gastric first primary cancer.
    Morais S; Antunes L; Bento MJ; Lunet N
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):471-477. PubMed ID: 30601339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan.
    Huang PC; Huang CY; Huang SW; Lai MK; Yu HJ; Chen J; Pu YS
    Int J Urol; 2006 Jul; 13(7):864-9. PubMed ID: 16882044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.
    Yamashita T; Araki K; Tomifuji M; Tanaka Y; Harada E; Suzuki T; Miyamoto S; Shiotani A
    Asia Pac J Clin Oncol; 2017 Jun; 13(3):172-178. PubMed ID: 27783469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Types of second primary cancer influence overall survival in cutaneous melanoma.
    Zheng G; Chattopadhyay S; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
    BMC Cancer; 2021 Oct; 21(1):1123. PubMed ID: 34663263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of kidney transplant tourism and risk factors for de novo urothelial carcinoma.
    Tsai HL; Chang JW; Wu TH; King KL; Yang LY; Chan YJ; Yang AH; Chang FP; Pan CC; Yang WC; Loong CC
    Transplantation; 2014 Jul; 98(1):79-87. PubMed ID: 24879380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased incidence of a second lymphoproliferative malignancy in patients with multiple myeloma--a SEER based study.
    Chakraborty S; Hauke RJ; Bonthu N; Tarantolo SR
    Anticancer Res; 2012 Oct; 32(10):4507-15. PubMed ID: 23060579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of independent second malignancies after non-muscle-invasive bladder cancer.
    Zecha H; Schmid HP; Tschopp A; Sulser T; Engeler DS
    Scand J Urol Nephrol; 2011 Sep; 45(4):245-50. PubMed ID: 21443417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers.
    Azad AK; Bairati I; Samson E; Cheng D; Cheng L; Mirshams M; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
    Cancer; 2012 Mar; 118(6):1554-65. PubMed ID: 22009713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urothelial carcinoma in patients with advanced kidney disease: a 12-year retrospective cohort survey.
    Hung PH; Shen CH; Tsai HB; Hsiao CY; Chiang PC; Guo HR; Hung KY
    Am J Med Sci; 2011 Aug; 342(2):148-52. PubMed ID: 21747280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study.
    Park SM; Lim MK; Jung KW; Shin SA; Yoo KY; Yun YH; Huh BY
    J Clin Oncol; 2007 Oct; 25(30):4835-43. PubMed ID: 17947733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary and second primary cancer in 649 patients with malignancies of the maxillofacial region.
    Friedrich RE
    Anticancer Res; 2007; 27(4A):1805-18. PubMed ID: 17649777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.
    Heudel PE; Fervers B; Durand T; Chabaud S; Michallet AS; Gomez F; Rivoire M; Bachelot T; Claude L; Chassagne-Clement C; Pilleul F; Mognetti T; Russias B; Soubirou JL; Chvetzoff G; Pérol D; Blay JY
    Int J Clin Oncol; 2021 Oct; 26(10):1793-1804. PubMed ID: 34091824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between multiple cutaneous melanoma and other primary neoplasms.
    Manganoni AM; Pavoni L; Farisoglio C; Sereni E; Chiudinelli M; Calzavara-Pinton P
    Clin Exp Dermatol; 2012 Dec; 37(8):857-61. PubMed ID: 23020153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediagnosis obesity and secondary primary cancer risk in female cancer survivors: A national cohort study.
    Jung SY; Kim YA; Jo M; Park SM; Won YJ; Ghang H; Kong SY; Jung KW; Lee ES
    Cancer Med; 2019 Feb; 8(2):824-838. PubMed ID: 30652416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.